Atlas Trials

A Study of the Effectiveness of Risk Minimization Measures Related to Depakine® (Sodium Valproate) in Saudi Arabia

Clinical trial NCT06714448 · COMPLETED

Trial details

NCT number
NCT06714448
Sponsor
Sanofi
Status
COMPLETED
Study type
OBSERVATIONAL
EpilepsySeizures
Start date
2025-04-29
Primary completion
2025-09-22
Enrollment
455

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.